Announcement on Subscription of Private Equity Shares
Filed with SSE · · 8 pages · Chinese
Summary by 6ix AI
Jinyu Bio-Technology Co., Ltd. has announced its subscription to a private equity fund. This investment aims to enhance the efficiency of the company's capital utilization without affecting its normal operations. The filing includes risk warnings associated with the investment, emphasizing the absence of capital protection or guaranteed returns.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/jinyu-bio-technology-co-ltdannouncement-on-subscription-of-private-equity-shares
Jinyu Bio-Technology Co., Ltd. on 6ix
Earlier from Jinyu Bio-Technology
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Obtaining Letter of Commitment for Special Loans for Stock Repurchase from Financial Institution
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares Repurchase
- Scheme for Repurchasing Shares through Call Auction
Later from Jinyu Bio-Technology
- Announcement on Expected Increase in Semi-annual Performance for 2026
- Announcement on the Completion of the Cancellation of Repurchased Shares and Share Changes
- Announcement on the Subsidiary Obtaining Approval to Manufacture Multivalent Foot-and-Mouth Disease Vaccine (SAT 1)
- Announcement on Progress in Repurchasing Shares through Call Auction
- Indicative Announcement on Changes in Equity Interests of Shareholders Holding More Than 5% of the Shares and Their Persons Acting in Concert Reaching the 1% Threshold
Follow Jinyu Bio-Technology into a list and get an email when it puts out news.
Follow Jinyu Bio-Technology